Cargando…
Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
Introduction: The pathological progression of non-alcoholic fatty liver disease (NAFLD) is driven by multiple factors, and non-alcoholic steatohepatitis (NASH) represents its progressive form. In our previous studies, we found that bicyclol had beneficial effects on NAFLD/ NASH. Here we aim to inves...
Autores principales: | Wu, Jingyi, Jia, Shu, Xu, Benhong, Yao, Xiaokun, Shao, Jingping, Yao, Jianzuo, Cen, Danwei, Yao, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063911/ https://www.ncbi.nlm.nih.gov/pubmed/37007016 http://dx.doi.org/10.3389/fphar.2023.1157200 |
Ejemplares similares
-
Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Frontiers Production Office,
Publicado: (2023) -
Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum
por: Yao, Jianzuo, et al.
Publicado: (2022) -
Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
por: Li, Hongxue, et al.
Publicado: (2021) -
Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021) -
Current, emerging, and potential therapies for non-alcoholic steatohepatitis
por: Yang, Zhen, et al.
Publicado: (2023)